COVID-19











Albany pumps $40M into biotech commercialization

By GREGORY ZELLER // Good news for Long Island’s impressive biotech-research corridor: New York State has opened a new Biodefense Commercialization Fund designed to speed promising life-science research to market….



Risk, opportunity in COVID/climate change combo

By MICHAEL H. SAHN // The climate-change crisis is accelerating. COVID is surging, particularly the Delta variant. Both present immediate challenges – and, quite interestingly, recent research shows there are…